Ascendis Pharma A/S (ASND) earnings, May 7, 2026: EPS +733%, stock +4.3%
In brief
Ascendis Pharma A/S reported on May 7, 2026. Earnings per share changed +733% year over year, 5,900.7% above the estimate; revenue +151%. The stock opened with a −5.3% gap and closed the day +4.3% (May 7, 2026). The stock is now 10.2% below its 52-week high, +28.2% over 12 months. Next report: Nov 11, 2026.
EPS vs estimate+5,900.7%
EPS, YoY+733%
Revenue, YoY+151%
Gap · day−5.3% · +4.3%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 7, 2026 | −5.3% | +4.3% |
Next-quarter estimates, ratings and the ASND chart are in the terminal.
Open the terminalFAQ
When is Ascendis Pharma A/S's next earnings report?
Nov 11, 2026. The date comes from daily data and is corrected if the company moves it.
How did Ascendis Pharma A/S stock react to the report?
Opening gap −5.3%, day's result +4.3%.
Did Ascendis Pharma A/S's earnings grow?
Earnings per share rose 733% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.